Abstract:The Lamarckian genetic algorithm of AutoDock 3.0 has been used to dock 27 3(S)-amino-2(S)-hydroxyl-4-phenylbutanoic acids (AHPBAs) into the active site of HIV-1 protease (HIVPR). The binding mode was demonstrated in the aspects of the inhibitor's conformation, subsite interaction, and hydrogen bonding. The data of geometrical parameters (tau(1), tau(2), and tau(3) listed in Table 2) and root mean square deviation values as compared with the known inhibitor, kni272,(28) show that both kinds of inhibitors interact with HIVPR in a very similar way. The r(2) value of 0.860 indicates that the calculated binding free energies correlate well with the inhibitory activities. The structural and energetic differences in inhibitory potencies of AHPBAs were reasonably explored. Using the binding conformations of AHPBAs, consistent and highly predictive 3D-QSAR models were developed by performing CoMFA, CoMSIA, and HQSAR analyses. The reasonable r(corss)(2) values were 0.613, 0.530, and 0.717 for CoMFA, CoMSIA, and HQSAR models, respectively. The predictive ability of these models was validated by kni272 and a set of nine compounds that were not included in the training set. Mapping these models back to the topology of the active site of HIVPR leads to a better understanding of vital AHPBA-HIVPR interactions. Structural-based investigations and the final 3D-QSAR results provide clear guidelines and accurate activity predictions for novel HIVPR inhibitors.

QSAR Study on Pyranones for Inhibitor of HIV Protease

Quantitatives Structure-Activity Relationship and Modification of HIV Protease Inhibitors

Molecular Modeling Studies of N-Substituted Pyrrole Derivatives - Potential Hiv-1 Gp41 Inhibitors

QSAR of 1-cyclopropyl-6-fluoro-7-substituted-1,4-dihydro 4-oxoquinoline-3-carboxylic acids for anti-HIV activity

QSAR Studies on 1-Aryl-tetrahydroisoquinoline Analogs As Active Anti-HIV Agents Based on PSO-v-SVM

Docking Field-Based QSAR and Pharmacophore Studies on the Substituted Pyrimidine Derivatives Targeting HIV-1 Reverse Transcriptase

The Qsar Research of Pyrrolobenzothiazepinones and Pyrrolobenzo-Xazepinones - Novel and Specific Non-Nucleoside Hiv-1 Reverse Transcriptase Inhibitors

QSAR studies for diarylpyrimidines against HIV-1 reverse transcriptase wild-type and mutant strains.

Similar Pyridinone Compounds with Different Activities of Anti-Hiv-1 Reverse Transcriptase

Screening Novel HIV-1 Protease Inhibitors Based on the Substrate Envelope Hypothesis

QSAR Study of Carboxylic Acid Derivatives As HIV-1 Integrase Inhibitors

Evaluation of Novel HIV-1 Protease Inhibitors with DRV-resistance by Utilizing 3D-QSAR Molecular Docking and Molecular Dynamics Simulation

QSAR of 1-cyclopropyl-6-fluoro-7-substituted-1,4-dihydro-4-oxoquinoline-3-carboxylic acids for anti-HTV activity

Elucidating the Inhibiting Mode of AHPBA Derivatives Against HIV-1 Protease and Building Predictive 3D-QSAR Models

The Design And Synthesis Of 9-Phenylcyclohepta[D]Pyrimidine-2,4-Dione Derivatives As Potent Non-Nucleoside Inhibitors Of Hiv Reverse Transcriptase

Docking and field-based QSAR studies of S-DABOs as HIV-1 reverse transcriptase inhibitors

Three dimensional quantitative structure-activity relationship of DATA analogues as HIV-1 reverse transcriptase inhibitors

Synthesis and Biological Evaluation of Pyridinone Analogues As Novel Potent HIV-1 NNRTIs.

Pharmacophore Modeling, 3D‐QSAR Studies, and In‐silico ADME Prediction of Pyrrolidine Derivatives As Neuraminidase Inhibitors

QSAR Studies of Anti-HIV Drug HEPT Using 3D-Hovaif

Synthesis and Anti-HIV-1 Activity Evaluation for Novel 3a,6a-Dihydro-1H-pyrrolo[3,4-c]pyrazole-4,6-dione Derivatives.